US Patent

US10736896 — Substituted 5-fluoro-1H-pyrazolopyridines and their use

Composition of Matter · Assigned to Adverio Pharma GmbH · Expires 2031-05-19 · 5y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects novel substituted 5-fluoro-1H-pyrazolopyridines and their use in treating and preventing cardiovascular disorders.

USPTO Abstract

The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Drugs covered by this patent

Patent Metadata

Patent number
US10736896
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-05-19
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Adverio Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.